KEATON MOORE: Open Payments
NPI 1548016488 · SOUTH CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,576 in 206 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $1,340 · 2025 $3,576
Food & beverage: $3,576
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 37 | $607 |
| AstraZeneca Pharmaceuticals LP | 18 | $363 |
| ABBVIE INC. | 20 | $331 |
| Amgen Inc. | 19 | $245 |
| GlaxoSmithKline, LLC. | 10 | $233 |
| Axsome Therapeutics, Inc. | 9 | $203 |
| Lilly USA, LLC | 12 | $183 |
| Dexcom, Inc. | 10 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $142 |
Products named: Ozempic, Wegovy, MOUNJARO, Rybelsus, Dexcom G6 Transmitter, AIRSUPRA, REPATHA, Kerendia.
Industry payments across WV — which companies pay providers there.
